---
figid: PMC3322195__crt-44-1-g002
figlink: /pmc/articles/PMC3322195/figure/F2/
number: Fig. 2
caption: Mechanism for synthetic lethality in BRCA1/2 deficient cancer. Poly ADR-ribose
  polymerase (PARP) inhibition produces tumor-selective synthetic lethaity. When PARP
  action is inhibited, SS are converted to DSB at replication. In cells with functional
  HR pathway, the DSB will be repaired. In cells with a dysfunctional HR pathway,
  as is the case with BRCA 1 and 2, the lesions go unrepaired and cell death ensues
  [,,]. BRCA, breast cancer susceptibility gene; DSB, double-strand break; HR, homologous
  recombination; SSB, single-strand break.
pmcid: PMC3322195
papertitle: Present Status and Problems on Molecular Targeted Therapy of Cancer.
reftext: Nagahiro Saijo. Cancer Res Treat. 2012 Mar;44(1):1-10.
pmc_ranked_result_index: '57574'
pathway_score: 0.7828994
filename: crt-44-1-g002.jpg
figtitle: Mechanism for synthetic lethality in BRCA1/2 deficient cancer
year: '2012'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3322195__crt-44-1-g002.html
  '@type': Dataset
  description: Mechanism for synthetic lethality in BRCA1/2 deficient cancer. Poly
    ADR-ribose polymerase (PARP) inhibition produces tumor-selective synthetic lethaity.
    When PARP action is inhibited, SS are converted to DSB at replication. In cells
    with functional HR pathway, the DSB will be repaired. In cells with a dysfunctional
    HR pathway, as is the case with BRCA 1 and 2, the lesions go unrepaired and cell
    death ensues [,,]. BRCA, breast cancer susceptibility gene; DSB, double-strand
    break; HR, homologous recombination; SSB, single-strand break.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PARP8
  - TNKS2
  - PARP9
  - PARP2
  - PARP3
  - BRCA2
  - BRCA1
  - PARP10
  - PARP12
  - PARP6
  - TIPARP
  - PARP15
  - TNKS
  - PARP16
  - PARP1
  - PARP4
  - PARP11
  - PARP14
genes:
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP8
  entrez: '79668'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS2
  entrez: '80351'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP9
  entrez: '83666'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP2
  entrez: '10038'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP3
  entrez: '10039'
- word: BRCA
  symbol: BRCA
  source: bioentities_symbol
  hgnc_symbol: BRCA2
  entrez: '675'
- word: BRCA
  symbol: BRCA
  source: bioentities_symbol
  hgnc_symbol: BRCA1
  entrez: '672'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP10
  entrez: '84875'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP12
  entrez: '64761'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP6
  entrez: '56965'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TIPARP
  entrez: '25976'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP15
  entrez: '165631'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS
  entrez: '8658'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP16
  entrez: '54956'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP1
  entrez: '142'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP4
  entrez: '143'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP11
  entrez: '57097'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP14
  entrez: '54625'
chemicals: []
diseases: []
---
